GLUL and cancer: However, Inhibition of glutamine synthetase (GS) with an antagonist, glufosinate, can impair cancer metastasis in several mouse tumor models, which is associated with blockade of immunosuppression and angiogenesis and re-education of TAMs to an anti-neoplastic type (148).